Registered entities
Genesis Therapeutics, Inc.
Reg. No. 833198117United States
Innovation
25 patent families (1 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace accelerating. Cited 445 times.
| Year | Filings |
|---|---|
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 14 |
| 2025 | 11 |
| 2026 | 1 |
Social engagement
Social engagement: 26.9K social following, 1 post in the last 12 months — below the industry typical range.
Investor mix
18 investors on record; lead investors include NVentures, Andreessen Horowitz, Rock Springs Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 61% |
| Private equity | 1 | 6% |
| Other / undisclosed | 6 | 33% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
31 Oct 2025 · Principal CADD Scientist · San Diego
Based on job postings tracked across public sources.
Recent activity
2 Jul 2026
Event
GenBio 2026 workshop at ICML Int'l Conference on Machine Learning